HEALTHY AGEING, stage project, multi-morbidity

WORK PACKAGE 4 OBJECTIVE

To identify multi-morbidity patterns in a whole-life context, modelling its trajectories across someone’s lifetime. This includes examining lifestyle, socioeconomic, environmental and biological factors, and estimating the economic cost of multi-morbidity. Ultimately, WP4 will identify proactive health-focused actions that can be taken.

WHY IS WP4
IMPORTANT?

Multi-morbidity is the presence of more than one long-term health condition in an individual. With an ageing population across Europe, it is vital that we understand how these conditions arise and interact with each other as we age.

Understanding how our environment, lifestyle and circumstances can influence multi-morbidity later in life could lead to more targeted, earlier interventions and policies.

healthy ageing, stage project

WP4 ACTIVITIES AND INTERLINKAGES

WP4 will perform a range of research-based, evidence-led work into multi-morbidity. As such, it is a central component of the STAGE project, and the findings will feed into other work packages throughout the project. Key tasks include:

T4.1

DEFINING MULTI-MORBIDITY

Assess consensus within the consortium about an operational definition of multi-morbidity using a life-course perspective to create a handbook to guide the project’s research on multi-morbidity. Patterns will be identified, mapped, visualised and compared using several factors.

T4.2

MODELLING MULTI-MORBIDITY

Characterising the trajectories of multimorbidity using data to explore patterns in a pre-selected set of diseases and conditions. This involves exploring how conditions cluster together and their combined impact on wellbeing and developing models to assess and project the future prevalence of multi-morbidity in individuals.

T4.3

MODELLING EXPOSURES AS MODERATORS OF AGEING TRAJECTORIES

Exploring multiple exposures (the exposome) as moderators of multi-morbidity and the influence of age on those exposures. The relationship between multi-morbidity states and the exposome will be examined along with the impact of targeted interventions.

T4.4

ECONOMIC IMPACTS

Examining the economic impacts associated with multi-morbidity, creating a framework to assess the health and socio-economic resilience of an individual to deal with multi-morbidity. ‘What-if’ policy-relevant scenario simulation will be used to understand the effects of interventions.

WP4 KEY OUTPUTS

Visualisation of Multi-Morbidity Patterns

Status: Ongoing

Multi-Morbidity Moderators of Ageing Trajectories

Status: Ongoing

Multi-Morbidity Models

Status: Ongoing

Policy Scenarios and Estimated Economic Impacts

Status: To be developed

WP4 STAKEHOLDER
IMPACTS

  • A more comprehensive understanding of how multi-morbidity can affect individuals throughout their lives and interventions that can make a difference.
  • Practical information on the impact of multi-morbidity and the exposome in an economic context. This will include a thorough examination of socio-economic and environmental determinants, which may help influence policy.
  • Creation of predictive ‘what-if’ policy scenarios to support evidence-based policy decisions.
healthy ageing, stage project

WP4 PARTNERS

With support from many of the STAGE partners, WP4 tasks are being undertaken by:

University of Rome Tor Vergata

Work Package Co-Lead

Italy

Amsterdam University Medical Centres

Work Package Partner

Netherlands

University of Oulu

Work Package Partner

Finland

University of Utrecht

Work Package Partner

Netherlands

University of Bristol

Work Package Partner

England

Region Hovedstaden

Work Package Co-Lead

Denmark

Erasmus University Medical Centre Rotterdam

Work Package Partner

Netherlands

University of Turin

Work Package Partner

Italy

Imperial College London

Work Package Partner

United Kingdom

“Taking a life-course approach to understand the moderators of ageing and how they influence the development of multi-morbidities will allow us to better target earlier interventions. This, together with a practical understanding of the economic impact of multi-morbidity in Europe, can help the project to influence policy priorities which work towards healthy ageing.”

Andrea Piano Mortari and Jennifer Baker (WP Co-Leaders)

Meet some of the WP4 partners in the video interview below and learn more about the work conducted by the work package.

Previous:

WP3

Cross-EU healthy ageing
neighbourhood atlas

Next:

WP5

Biological hallmarks of ageing

SUBSCRIBE TO OUR NEWSLETTER

Join our mailing list to receive the latest project news

Privacy

Your subscription

By subscribing to this list, you accept to receive information about events, news and/or newsletters about the STAGE project. The personal data collected will only be used to send you the newsletter(s) you chose to opt in to above. You can change your mind at any time by clicking the "unsubscribe" link in the footer of any email you receive from us. We will treat your information with respect.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.